Voyager Therapeutics (VYGR) Net Margin Growth (3y) (2018 - 2026)
Powered by 
Analysis
Voyager Therapeutics (VYGR) Net Margin Growth (3y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | -78,467.00 |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | 4.47 Mn |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | 29,163.00 |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | 143,941.00 |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | -2.46 Mn |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | 118,642.00 |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | 795.00 |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | 1,380.00 |
| 10 | Voyager Therapeutics | 215.07 Mn | 98.73 Mn | - | -31,156.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -31,156.00 |
| Mar 31, 2026 | -115,693.00 |
| Dec 31, 2025 | -153,869.00 |
| Sep 30, 2025 | -25,104.00 |
| Jun 30, 2025 | 203,880.00 |
| Mar 31, 2025 | 276,272.00 |
| Dec 31, 2024 | -56,967.00 |
| Sep 30, 2024 | 165,943.00 |
| Jun 30, 2024 | 207,245.00 |
| Mar 31, 2024 | 33,539.00 |
| Dec 31, 2023 | 30,625.00 |
| Sep 30, 2023 | -63,401.00 |
| Jun 30, 2023 | -42,095.00 |
| Mar 31, 2023 | 21,476.00 |
| Dec 31, 2022 | 156,274.00 |
| Sep 30, 2022 | 11,634.00 |
| Jun 30, 2022 | -270,496.00 |
| Mar 31, 2022 | -271,717.00 |
| Dec 31, 2021 | 114,240.00 |
| Sep 30, 2021 | -72,724.00 |